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ABSTRACT                        Antimicrobial peptides (AMPs) are an evolutionarily conserved component of the 
innate immune response and they were found among all classes of life forms. In the present 
study AMPs were extracted from the hemolymph of Antheraea mylitta and fractionated by High 
Performance Liquid Chromatography (HPLC). Antimicrobial activity was tested against three 
clinically isolated multidrug-resistant (MDR) bacteria, such as urinary tract infecting Escherichia 
coli, wound infecting Pseudomonas aeruginosa and Bacillus pumilus. Fraction I (comprised of 
three different peptides of varying mass) did not inhibit the growth of any of these clinical 
isolates, whereas, fraction III inhibited the growth of B. pumilus without affecting the growth 
of gram-negative isolates. Fraction II exhibited bactericidal effects against P. aeruginosa and 
E. coli, whereas, B. pumilus was not susceptible. Scanning electron microscopic study revealed 
that serious structural alterations of cell morphology and disruption of the outer membrane, 
that facilitates the release of cytoplasmic content through holes and channels in E. coli, treated 
with this isolated peptide. Our results indicate that the peptide from the isolated fraction could 
be used as potent alternative antimicrobial compounds for the treatment of MDR E. coli and 
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Introduction
Every living organism on Earth has their own self-defense 
mechanism of producing a versatile group of soluble factors, 
which have the immense role in both innate and adaptive im-
mune systems. In higher animals, soluble factors, particularly 
bioactive peptides are the sole ‘attacking weapons’ against 
invading pathogens. More than 2000 AMPs have been isolated 
from plants and animals, which were identified until today. 
Their amino acid composition, charge and size allow them 
to cross the outer barriers in both gram-positive and gram-
negative bacteria, fungi and some viruses to form non-specific 
pore, damage and kill the microorganisms (Bencsik 2013). 
Many antimicrobial components have been evaluated between 
1920 and 1950, but their applicability as therapeutic agents 
has been considered just in the last 15 years. They represent 
promising compounds for the treatment of infections to eradi-
cate MDR microbes. In addition to the treatment of infectious 
diseases, AMPs are used in novel therapeutics development 
for other diseases, such as atopic dermatitis, Crohn’s disease, 
cystic fibrosis (Zhang et al. 2005) and tumors (Hilchie et al. 
2011). Considering its immense importance, pharmaceutical 
industries in the last five years have exhausted more than 30 
billion dollars for the development of this novel drug type 
(Kang et al. 2014). 
Both in developed and developing countries worldwide, 
MDR bacterial infections are very frequent and their number 
is increasing day by day, due to improper use of antibiotics 
and health care deficiencies. In developing countries, noso-
comial infections are one of the greatest threats and make 
expensive to control, due to poor hygienic and environmental 
conditions. It has been reported, that approximately 150 mil-
lion people suffer from urinary tract infection (UTI) in each 
year around the world (Stamm et al. 2001), in which 75% are 
women between the age group of 16-35 years (Nicolle 2008; 
Salvatore et al. 2011). UTI is a common bacterial infection, 
mostly caused by E. coli and about 75-95% uncomplicated 
UTI is mediated by E. coli. In India the risk of E. coli me-
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diated UTI is 63.44%, followed by other organisms like 
Klebsiella sp. (14.62%), Pseudomonas sp. (4.53%), Proteus 
sp. (4.62%) and other bacteria (Maji et al. 2013). Antibiotic 
resistance in gram-negative bacteria, particularly in E. coli 
is common, due to the spread of strains producing extended-
spectrum β-lactamases, such as CTX-M enzymes (Pallett 
and Hand 2010). Pseudomonas aeruginosa is another com-
mon causative agent for burns, wounds, airways and urinary 
tract infection, also causes septicemia. One in ten hospitals, 
acquired infections are caused by Pseudomonas sp. In case 
of skin infection, its exotoxin A is responsible for hemor-
rhage and necrosis. The antibiotic resistance mechanism of 
P. aeruginosa has the inherent capacity to produce four-five 
factors that can facilitate its growth even in mixed antibiotics-
treated condition. It has reported that, 75% mortality due to 
burn, is directly caused by P. aeruginosa (Koller et al. 1999; 
Guggenheim et al. 2011). Due to natural adaptation, bacteria 
develop many mechanisms to avoid the actions of antibiot-
ics, including ejecting out, efflux, changing the antibiotic 
attacking site or by modifying/cleaving the antibiotics (Ra-
jaduraipandi et al. 2014; Mukherjee et al. 2007).
Earlier reported, that silkworm Bombyx mori produces 
antibacterial protein attacin (~20 kDa) and gloverin (~14 kDa) 
have abilities to kill E. coli (Carlsson et al. 1998). The effi-
cacy of a peptide rich hemolymph extract of B. mori has been 
proved to have growth inhibitory effects on human pathogenic 
bacteria, such as S. aureus, P. aeruginosa, E. coli and it also 
suppresses the growth of tumor cells (Moselhy et al. 2012). 
Antheraea mylitta, a tropical tasar silkworm, endemic to 
India, possess an enormous number of microorganisms, 
including microsporidia (Hassan and Nath 2014). This made 
us curious to investigate its hemolymph in search of novel 
antimicrobial substances. An antifungal protease inhibitor 
(AmFPI-1) was characterized from A. mylitta hemolymph as 
an effective inhibitor of Aspergillus oryzae (Shrivastava et al. 
2003). Analysis of fat body Expressed Sequence Tag (EST) 
library of bacterial challenged A. mylitta larvae (Gandhe et al. 
2006) achieved, which revealed that A. mylitta contains tran-
scripts of various AMPs, such as cecropin, attacin, gloverin 
and lebocin. No any information is available in the literature 
about the full AMP profile of A. mylitta hemolymph. In the 
present study, it is further characterized by isolating novel 
representatives and investigation of their antibacterial activ-




Eschericia coli DH5α strain was grown in LB (lysogeny 
broth) medium in absorbance at 600 nm. Bacteria were 
washed with PBS (phosphate buffer saline) and 10 µl of 107 
bacterial cell/ml was injected into the haemocoel of A. mylitta 
larvae. After 24 h of post infection, larvae were chilled on 
ice and hemolymph was collected by cutting appendages in 
prechilled tubes. The hemocyte free hemolymph was obtained 
by centrifugation at 500 g for 10 min and then centrifuged 
further at 13 500 g for 15 min at 4 ºC to remove other cell 
debris and stored at -20 ºC.
Preparation of hemolymph extracts
Acidic/methanolic extracts of hemolymph were prepared by 
the method of Schoofs et al. (1990). The hemolymph was 
diluted 10 times with the extraction solution consisting of 
methanol:glacial acetic acid:water (90:1:9; v/v/v) and mixed 
thoroughly. Precipitated proteins were pelleted by centrifuga-
tion at 20 000 g for 30 min at 4 ºC. The obtained supernatant 
was freeze-dried and dissolved in 0.1% (v/v) trifluoroacetic 
acid (TFA) followed by removal of lipids with n-hexane. This 
extract was mixed with equal volume of ethyl acetate, cen-
trifuged and finally the aqueous phase, containing peptides, 
was lyophilized and stored at -20 °C.
Isolation and characterization of clinically 
isolated bacteria
Bacteria, such as E. coli and P. aeruginosa were isolated from 
urine and wound samples at Bankura Sammilani Medical Col-
lege & Hospital (West Bengal, India). These organisms were 
isolated and biochemically identified with standard methods 
described elsewhere (Bhatia and Ichhpujani 2008).
Bacteria were also identified by sequencing the 16S rRNA 
gene. In brief, cells were grown in LB medium and pelleted 
by centrifugation at 8600 g for 3 min at 4 °C. Pellets were 
resuspended in 5 ml buffer (1.4 M NaCl, 10 mM EDTA, 
0.5%, (w/v) SDS, and 100 mM Tris-HCl, pH 8.0) containing 
proteinase K and RNase A at a final concentration of 100 µg/
ml and incubated at 56 °C for 30 min. Then, it was extracted 
twice with equal volume of phenol:chloroform:isoamyl al-
cohol (25:24:1, v/v/v) by gentle mixing and centrifuged at 
12 400 g for 15 min at 4 °C. From the upper aqueous phase, 
DNA was precipitated by adding an equal volume of iso-
propanol and 0.1 volumes of 3 M sodium acetate (pH 5.2). 
DNA was pelleted by centrifugation at 13 500 g for 20 min 
at 4 °C, washed thrice with 70% (v/v) ethanol, air dried and 
finally suspended in 50 µl of TE buffer. Quantity and quality 
of DNA were determined with a Nanodrop 2000 UV-VIS 
Spectrophotometer (Thermo Fisher Scientific, Inc., Waltham, 
MA, USA) by checking OD at 260 nm and performing 1% 
agarose gel electrophoresis, respectively. Polymerase chain 
reaction (PCR) for the amplification of 16S rRNA was carried 
out as follows: reaction mixture contained 30 ng of template 
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DNA, 1 pmol of each primer (27 F: 5′ AGAGTTTGATCMT-
GGCTCAG 3′; 518 R: 5′ CGTATTACCGCGGCTGCTGG 
3′), 1 × PCR buffer (20 mM Tris-HCl, pH 8.4, 50 mM KCl), 
2.5 mM MgCl
2
, 1 unit of Taq DNA polymerase (5 U/µl), 0.2 
mM dNTPs (Bioline) and adjusted to the final volume (20 µl) 
with nuclease free water. PCR was carried out in a GeneAmp 
9700 PCR system (Applied Biosystems) for 35 cycles after 
an initial denaturation for 4 min at 94 ºC. Each PCR cycle 
comprised of three steps: denaturation at 94 ºC for 1 min, an-
nealing at 58 ºC for 1 min and extension at 72 ºC for 1.5 min 
with a final extension of 7 min at 72 ºC. A negative control 
without template DNA was also used. The amplified PCR 
products were analyzed by gel electrophoresis on 1% agarose 
gel observed under UV transilluminator and photographed 
in a gel documentation system (Kodak). Amplicons were se-
quenced by using Bigdye Terminator v3.1 Cycle Sequencing 
Kit (Applied Biosystems), in an automated DNA sequencer 
(3500 series Genetic Analyzer, Applied Biosystems) based 
on the manufacturer’s instructions. Alongside, a bacterium, 
Bacillus sp. isolated from soil was subjected for molecular 
identification following the aforementioned technique. The 
sequences were analyzed by Sequencher software (Gene 
Codes Corporation, Ann Arbor, MI, USA) and homology 
were searched in NCBI tool using the BLAST (Basic Local 
Alignment Search Tool) method.
Antimicrobial assay of hemolymph extract
The bactericidal activity of hemolymph extract of A. mylitta 
was tested against E. coli, P. aeruginosa and B. pumilus iso-
lates grown on Mueller-Hinton agar (HiMedia Laboratories). 
The antibacterial efficacy of hemolymph extract and commer-
cial antibiotics were tested by the agar disk diffusion method 
as described by Bauer et al. (1966). The size of the disk was 
5 mm in diameter and contained 5 µl of hemolymph extract 
(2.3 mg/ml) or 20 µg of antibiotics (SRL Diagnostics). All 
plates were incubated at 37 °C for 24 h and zone of inhibition 
(mm) was measured.
Peptide purification and assay of antimicrobial 
activity
The lyophilized hemolymph extract was resuspended in 
distilled water and 50 µl of it was applied on reversed-phase 
high-performance liquid chromatography (RP-HPLC) (Agi-
lent 1200 Series, Agilent Technologies, USA) ZORBAX-SB-
C18 column (5 mm, 250 mm × 4.6 mm). Sterile Milli-Q water 
(Millipore) (A) and 80% (v/v) acetonitrile (B) containing 
0.1% (v/v) TFA were used as mobile phases. Linear gradient 
of solvent B (5-60%, v/v) was maintained for 50 min at 1 ml/
min flow rate. The elution was monitored at 220 nm in a diode 
array detector, equipped with the RP-HPLC system. Individ-
ual peak was collected separately, freeze dried, resuspended 
in distilled water and tested for antimicrobial activity.
The antibacterial activity of the three major peak fractions 
(I, II and III) eluted at 3.5, 7.4 and 11.5 min (after loading), fi-
nally, were tested again by using the same agar disk diffusion 
test as described earlier. The concentration of the peptides 
was monitored using a Nanodrop 2000 UV-VIS Spectropho-
tometer (Thermo Fisher Scientific, Waltham, MA, USA).
Thin layer chromatography (TLC)
The purity of peptides was also tested by TLC. Briefly, 5 µl 
of HPLC-purified peptides were spotted on a pre-coated silica 
plate (7 cm ×  10 cm) along with glycine as standard. The 
plates were run with a mobile phase solvent of butanol:acetic 
acid:water (3:1:1, v/v/v) for 1 h at room temperature. After 
air drying peptides were identified using 2% (w/v in butanol) 
ninhydrin as a coloring reagent.
Scanning electron microscopic analysis of the 
antimicrobial activity of the isolated peptide on 
E. coli
Mid-logarithmic phase E. coli culture was washed with PBS 
and finally resuspended in PBS (106 cell/ml). Fifty microliter 
of this cell suspension was incubated with 0.125 µg of HPLC-
purified peptide and incubated for 1.5 h at 37 ºC. Cells were 
then fixed with 4% glutaraldehyde at 4 ºC for 4 h, then washed 
with PBS and dehydrated with graded ethanol (40-100%), 
incubating 10 min at each alcohol concentration. Finally, 
bacterial pellet was resuspended with 100% alcohol, smeared 
on a coverslip, coated with gold and changes in bacterial cell 
morphology were studied by using an atmospheric scanning 
electron microscope (ASEM, ZEISS).
Results
Characterization of various bacterial isolates 
and effect of hemolymph extract
Clinical isolates of E. coli and P. aeruginosa were identified 
by standard biochemical procedures. Both the strains as well 
as Bacillus sp. were subsequently identified by 16S rDNA se-
quencing. Obtained sequences were searched in the Genbank 
database: the results of the homology search are presented in 
Table 1. Based on this, bacterial isolates were proved to be 
E. coli, P. aeruginosa and B. pumilus as it shows 76%, 83% 
and 91% nucleotide sequence identities, respectively, with the 
available sequences of the same organisms in the database. 
Hemolymph extract exhibited antimicrobial activity against 
all tested pathogenic bacterial isolates. Escherichia coli was 
resistant to cephalosporine and ampicillin (20 µg), but sensi-
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tive to hemolymph extract (11.5 µg). Similarly, P. aeruginosa 
showed resistance to cephalosporine, kanamycine, chloram-
phenicol and ampicillin (20 µg), but sensitive to hemolymph 
extract (11.5 µg). B. pumilus was proved to be sensitive to 
both hemolymph extract (11.5 µg) and ampicillin (20 µg). The 
zone of inhibition of bacterial growth by hemolymph extract 
was measured and depicted in Table 2.
Purification of antimicrobial peptide by RP-HPLC
Peptides, which present in the hemolymph extract were 
separated by RP-HPLC using a C18 column and three major 
peaks (I, II, and III) were collected (Fig. 1). Antimicrobial 
potencies of these fractions were evaluated and presented in 
Table 3. Fraction I did not show any inhibitory activity against 
the tested bacteria. Fraction II exhibited strong inhibitory 
action on E. coli (zone of inhibition is 9.0±0.35 mm) and P. 
aeruginosa (zone of inhibition is 6.5±0.40 mm). It is inter-
esting to note that fraction III exhibited antimicrobial effect 
on the gram-positive B. pumilus giving an inhibition zone of 
7.5±0.30 mm, but not onto the gram-negative isolates.
Characterization of peptides by thin layer 
chromatography
RP-HPLC purified fractions I, II and III were further sepa-
rated by thin layer chromatography with glycine as a migra-
tion control. A distinct and isolated spots of peptides were 
observed in TLC plates. The chromatogram also revealed 
that fractions II and III are homogeneous and contain a single 
Name of clinical isolates Sequence accession 
number in the 
database
Identities shown
E. coli AY996985.1 271/358 (76%)
P. aeruginosa KX109926.1 281/337 (83%)
B. pumilus JQ282821.1 448/495 (91%)
Table 1. 16 S rDNA sequence homology of isolated bacteria.
Table 2. Effect of A. mylitta hemolymph extract (11.5 µg) and 
ampicillin (20 µg) on E. coli, P. aeruginosa and B. pumilus.
Name of pathogen Zone of inhibition including disk (mm)
Hemolymph extract Ampicillin
E. coli 18±0.70 0
P. aeruginosa 11±0.35 0
B. pumilus 12±0.70 22±0.50
Figure 1. Reversed-phase HPLC chromatogram of A. mylitta hemolymph extract. Rectangle indicates fraction II, which showed antibacterial 
effects.
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type of peptide, whereas, fraction I contains three different 
peptides.
Scanning electron microscopy
The bactericidal activity of the isolated peptides on the E. coli 
was studied by scanning electron microscopy (SEM). Figure 
2 clearly demonstrates that alteration of cell morphology 
with depression and shrinkage of cell wall due to leakage of 
cytosol, indicating peptide (fraction II) mediated disruption of 
outer layers. In contrast, PBS treated cells showed compact, 
smooth and intact outer layers.
discussion
It is well-documented that insect hemolymph contains many 
antimicrobial substances, like melanin, immune proteins and 
AMPs to protect against invading pathogens as they do not 
have any adaptive immune system. Many AMPs like cecropin 
(Steiner 1982), attacin (Hultmark et al. 1983), defensin (Bulet 
et al. 1991) and gloverin (Kaneko et al. 2007) were identified 
in different order of insects, including Lepidoptera (Gandhe 
et al. 2006). Ravichandran et al. (2010) have reported that the 
crab hemolymph extract can kill Salmonella typhi and Kleb-
siella species. Similar report also noted in case of hemolymph 
extracts of diplopod, chilopod species (Xylander 1990), crab 
(Veeruraj 2008; Rethna and Chandran 2014), spider (Yigit and 
Benli 2008), shrimp (Kumaravel et al. 2010) and Mollusca 
(Vini et al. 2013).
Rapid emergence of MDR bacteria is a burning threat to 
human health worldwide; it raises the urge to develop some 
alternative compound, which would be effective against 
MDR pathogens. Here, for the first time we reported the 
antimicrobial activity of hemolymph extract of A. mylitta on 
MDR E. coli and P. aeruginosa. In addition, B. pumilus a food 
poisoning and diarrhea causing bacteria also included in this 
study. Moreover, it also infects skin and caused cutaneous 
ulcer, very similar to B. anthracis (Tena et al. 2007). MDR 
strains, as well as antibiotic sensitive B. pumilus were inhib-
ited by crude hemolymph extract of A. mylitta. The zone of 
inhibition in all the cases of RP-HPLC isolated peptides were 
small, because the amount of purified peptides used in the 
experiment was very low in amount (125 ng). The antibacte-
rial activity of fraction II is very similar to the AMP Api137 
(Berthold et al. 2013) and oncovin (Knappe et al. 2010), 
which also shows antimicrobial effects on pathogenic E. coli 
and P. aeruginosa.
Observation of peptide fraction II treated E. coli under 
SEM revealed massive structural deformation and depression 
in the cell wall caused by the disruption of the outer mem-
brane, which eventually leads to release of the cytoplasmic 
contents by opening membrane surface. Similar type of 
observation of the cell surface and leakage of cellular ma-
terials has also been made in case of Xanthomonas oryzae 
pv. oryzae and Shigella sp. treated with mellitin and venom 
of European honey bee (Shi et al. 2016) and spider Agelena 
labyrinthica (Yigit and Benli 2008). Polymerization of anti-
microbial peptide in the bacterial membrane (Zangger et al. 
2008) is the initial step of its permeation. It was found, that 
peptides rich in glycine residues remained untidy in aqueous 
environments and gradually inclined to order itself in contact 
with bacterial membrane upon polymerization (Nguyen et al. 
2008). A synthetic analog of keratin derived AMP-KDAMP 
was found to bind and penetrate the bacterial cell wall by 
upsetting membrane structure for its bactericidal activity 
against various human pathogens, like P. aeruginosa, E. coli, 
Streptococcus pyogenes and S. aureus. Therefore, it seems 
that the killing of E. coli and P. aeruginosa by our isolated 
peptide fraction II, possibly follow similar pattern as observed 
in case of KDAMPs and mellitin. In conclusion, hemolymph 
extract of Indian tasar silkworm A. mylitta contains effective 
antimicrobial peptides acts against clinically isolated MDR 
pathogenic bacteria and therefore, could be exploited as po-
tent alternative therapeutics.
Peptide fractions Zone of inhibition (mm) against tested organisms
E. coli P. aureginosa B. pumilus
I 0.0±0.00 0.0±0.00 0.0±0.00
II 9.0±0.35 6.5±0.40 0.0±0.00
III 0.0±0.00 0.0±0.00 7.5±0.30
Ampicillin 0.0±0.00 0.0±0.00 22.0±0.50
Table 3. Analysis of antibacterial activity of HPLC purified frac-
tions I, II, III and ampicillin against E. coli, P. aeruginosa and B. 
pumilus.
Figure 2. Scanning electron microscopy of untreated (C) and peptide 
treated (T) E. coli. Distortion of cell wall and pore formation was 
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